With the MRNA position closed out today, capital is freed up and ready to be redeployed. Entering a new position on CCJ (Cameco Corporation) — one of the world’s largest uranium producers — collecting solid premium at a strike I’m comfortable owning.
Trade Update
CCJ – New Entry
- 04/17/26 – Sell CCJ $109 Put @ $112
- Entered for attractive premium with a strike well below current trading price.
Why I Took It
- Uranium thesis is intact — CCJ is a fundamentally strong company in a sector with long-term tailwinds driven by the global push for nuclear energy
- $109 strike sits below current price — with CCJ trading around $112, the strike offers a comfortable buffer before assignment becomes a concern
- Solid premium for the risk — collecting $112 on a defined-risk trade is an attractive setup
- Clean re-entry after a strong exit — redeploying capital immediately after closing MRNA keeps the wheel turning efficiently
Two Outcomes (Both Acceptable)
- Expires worthless → Keep $112 and redeploy capital into the next opportunity
- Assigned shares → Own CCJ at $109 minus premium — a name I’m comfortable holding — and begin selling covered calls
CCJ can be sensitive to macro news around energy policy and nuclear regulation, so position sizing and active management will be key. The edge here isn’t predicting uranium prices — it’s collecting premium in a structured, disciplined way and letting the math work.
Small, consistent wins. That’s the goal.
Trade Details
- 04/17/26 — Sell CCJ $109 Put @ $112
- Premium collected: $112 per contract
- Max profit: $112 (if expires worthless)
- Breakeven: $107.88 per share
Fresh capital deployed on a strong underlying. The wheel keeps turning. 🔄